Healthcare provider profile · identity verified

Anna Harutyunyan, MD

Allopathic & Osteopathic Physicians|Internal Medicine · PARAMUS, NJ · NPI 1467610014

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Anna Harutyunyan, MD received $328.04 in general payments during 2025 across 3 reported records.

Gilead Sciences, Inc. accounted for 38.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

Gilead Sciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Vemlidy as an associated drug or biological on 782 records involving 554 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Vemlidy by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$328.04

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Gilead Sciences, Inc.	Unresolved — no canonical attribution shown	$124.98	38.1%	1	2025
Shionogi Inc	Unresolved — no canonical attribution shown	$110.16	33.6%	1	2025
Intra-Sana Laboratories	Unresolved — no canonical attribution shown	$92.90	28.3%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$328.04	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Biktarvy Normalized: biktarvy	Drug	Gilead Sciences, Inc.	$124.98	1	2025
Source payment records 2025-06-10 · Gilead Sciences, Inc. · $124.98 · Open Payments source
Fetroja Normalized: fetroja	Drug	Shionogi Inc	$110.16	1	2025
Source payment records 2025-11-13 · Shionogi Inc · $110.16 · Open Payments source
GLYCATE Normalized: glycate	Drug	Intra-Sana Laboratories	$92.90	1	2025
Source payment records 2025-09-09 · Intra-Sana Laboratories · $92.90 · Open Payments source
RELTONE 200 MG Normalized: reltone 200 mg	Drug	Intra-Sana Laboratories	$92.90	1	2025
Source payment records 2025-09-09 · Intra-Sana Laboratories · $92.90 · Open Payments source
RELTONE 400 MG Normalized: reltone 400 mg	Drug	Intra-Sana Laboratories	$92.90	1	2025
Source payment records 2025-09-09 · Intra-Sana Laboratories · $92.90 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Gilead Sciences, Inc. Exact reporting entity; no affiliate inference	2025	Vemlidy open payments reported associated product	CMS Open Payments — General Payments 782 supporting records · 554 recipient NPIs · example record 1234350906	Vemlidy · 2024 Exact normalized brand match · 1 Part D row	34	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	1342	97
Rosuvastatin Calcium	Rosuvastatin Calcium	795	120
Amlodipine Besylate	Amlodipine Besylate	598	93
Levothyroxine Sodium	Levothyroxine Sodium	505	76
Tamsulosin Hcl	Tamsulosin Hcl	489	71
Atorvastatin Calcium	Atorvastatin Calcium	421	81
Losartan Potassium	Losartan Potassium	421	73
Metoprolol Succinate	Metoprolol Succinate	387	61
Tramadol Hcl	Tramadol Hcl	384	27
Metformin Hcl	Metformin Hcl	357	61
Escitalopram Oxalate	Escitalopram Oxalate	339	53
Januvia	Sitagliptin Phosphate	337	30
Mirtazapine	Mirtazapine	331	54
Lorazepam	Lorazepam	329	44
Lactulose	Lactulose	316	33
Famotidine	Famotidine	303	54
Gabapentin	Gabapentin	295	47
Furosemide	Furosemide	281	49
Alendronate Sodium	Alendronate Sodium	273	39
Clopidogrel	Clopidogrel Bisulfate	253	39
Divalproex Sodium	Divalproex Sodium	229	54
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	221	51
Silver Sulfadiazine	Silver Sulfadiazine	221	49
Benztropine Mesylate	Benztropine Mesylate	212	34
Metoprolol Tartrate	Metoprolol Tartrate	204	46
Pantoprazole Sodium	Pantoprazole Sodium	196	49
Finasteride	Finasteride	185	29
Trulicity	Dulaglutide	181	suppressed
Donepezil Hcl	Donepezil Hcl	179	29
Potassium Chloride	Potassium Chloride	179	28
Midodrine Hcl	Midodrine Hcl	162	17
Levetiracetam	Levetiracetam	152	22
Clonazepam	Clonazepam	151	25
Latanoprost	Latanoprost	151	20
Mupirocin	Mupirocin	149	32
Quetiapine Fumarate	Quetiapine Fumarate	149	31
Fentanyl	Fentanyl	146	11
Trazodone Hcl	Trazodone Hcl	138	22
Ibuprofen	Ibuprofen	137	17
Tresiba	Insulin Degludec	134	31
Klor-Con M20	Potassium Chloride	133	18
Simvastatin	Simvastatin	132	26
Atenolol	Atenolol	130	18
Zenpep	Lipase/Protease/Amylase	129	suppressed
Meloxicam	Meloxicam	126	14
Baclofen	Baclofen	124	13
Santyl	Collagenase Clostridium Hist.	123	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	116	14
Hydralazine Hcl	Hydralazine Hcl	110	20
Alprazolam	Alprazolam	109	12
Carbidopa-Levodopa	Carbidopa/Levodopa	107	15
Valproic Acid	Valproic Acid (As Sodium Salt)	107	16
Nystatin	Nystatin	105	39
Memantine Hcl	Memantine Hcl	104	18
Olanzapine	Olanzapine	104	17
Chlorhexidine Gluconate	Chlorhexidine Gluconate	103	22
Lisinopril	Lisinopril	102	22
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	100	suppressed
Metformin Er Osmotic	Metformin Hcl	88	suppressed
Risperidone	Risperidone	86	21
Sertraline Hcl	Sertraline Hcl	86	20
Jardiance	Empagliflozin	85	17
Fenofibrate	Fenofibrate Nanocrystallized	84	13
Aripiprazole	Aripiprazole	82	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	81	11
Novolog	Insulin Aspart	80	22
Memantine Hcl Er	Memantine Hcl	78	suppressed
Montelukast Sodium	Montelukast Sodium	77	19
Duloxetine Hcl	Duloxetine Hcl	74	13
Esomeprazole Magnesium	Esomeprazole Magnesium	74	11
Omeprazole	Omeprazole	74	15
Lacosamide	Lacosamide	72	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	70	suppressed
Carvedilol	Carvedilol	68	21
Namzaric	Memantine Hcl/Donepezil Hcl	66	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	64	suppressed
Alogliptin	Alogliptin Benzoate	63	17
Bupropion Xl	Bupropion Hcl	62	suppressed
Methotrexate	Methotrexate Sodium	62	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	61	12
Scopolamine	Scopolamine	61	suppressed
Xarelto	Rivaroxaban	60	suppressed
Ketoconazole	Ketoconazole	59	22
Humalog	Insulin Lispro	56	13
Farxiga	Dapagliflozin Propanediol	55	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	55	23
Fluticasone Propionate	Fluticasone Propionate	53	19
Myrbetriq	Mirabegron	50	suppressed
Sucralfate	Sucralfate	50	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	49	suppressed
Budesonide	Budesonide	48	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	47	suppressed
Propranolol Hcl	Propranolol Hcl	47	suppressed
Amiodarone Hcl	Amiodarone Hcl	46	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	46	15
Dulera	Mometasone/Formoterol	46	suppressed
Torsemide	Torsemide	46	suppressed
Glycopyrrolate	Glycopyrrolate	44	suppressed
Digoxin	Digoxin	43	suppressed
Prednisone	Prednisone	43	13
Haloperidol	Haloperidol	42	12
Hydrocortisone	Hydrocortisone	42	24
Restasis	Cyclosporine	41	suppressed
Risperidone Odt	Risperidone	41	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	40	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	40	suppressed
Acetazolamide	Acetazolamide	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Lamotrigine	Lamotrigine	39	suppressed
Bethanechol Chloride	Bethanechol Chloride	38	suppressed
Loxapine	Loxapine Succinate	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	12
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Clonidine Hcl	Clonidine Hcl	36	suppressed
Glimepiride	Glimepiride	36	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	12
Risperidone Er	Risperidone Microspheres	36	suppressed
Creon	Lipase/Protease/Amylase	35	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	35	16
Loperamide	Loperamide Hcl	35	suppressed
Veltassa	Patiromer Calcium Sorbitex	35	suppressed
Alphagan P	Brimonidine Tartrate	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Cyclosporine	Cyclosporine	34	suppressed
Methimazole	Methimazole	34	suppressed
Timolol Maleate	Timolol Maleate	34	suppressed
Vemlidy	Tenofovir Alafenamide	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	11
Nyamyc	Nystatin	32	13
Oxcarbazepine	Oxcarbazepine	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	29	suppressed
Methocarbamol	Methocarbamol	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	12
Fluphenazine Decanoate	Fluphenazine Decanoate	28	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Linzess	Linaclotide	26	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	26	suppressed
Nitroglycerin Patch	Nitroglycerin	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	22
Entresto	Sacubitril/Valsartan	25	suppressed
Naproxen	Naproxen	25	suppressed
Ozempic	Semaglutide	25	suppressed
Atazanavir Sulfate	Atazanavir Sulfate	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Folic Acid	Folic Acid	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Phenobarbital	Phenobarbital	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Lumigan	Bimatoprost	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Insulin Degludec	Insulin Degludec	22	14
Ritonavir	Ritonavir	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	17
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Levemir	Insulin Detemir	21	15
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Lamivudine-Zidovudine	Lamivudine/Zidovudine	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Topiramate	Topiramate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Haloperidol Lactate	Haloperidol Lactate	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Repaglinide	Repaglinide	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Levofloxacin	Levofloxacin	17	13
Nateglinide	Nateglinide	17	suppressed
Tacrolimus	Tacrolimus	17	suppressed
Fiasp	Insulin Aspart (Niacinamide)	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Letrozole	Letrozole	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Methylprednisolone	Methylprednisolone	15	13
Quetiapine Fumarate Er	Quetiapine Fumarate	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Glipizide	Glipizide	14	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	13	13
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fycompa	Perampanel	13	suppressed
Glatiramer Acetate	Glatiramer Acetate	13	suppressed
Oxytrol	Oxybutynin	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Cefuroxime	Cefuroxime Axetil	12	11
Cholestyramine Light	Cholestyramine	12	suppressed
Demeclocycline Hcl	Demeclocycline Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	12	12
Risedronate Sodium	Risedronate Sodium	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Brinzolamide	Brinzolamide	11	suppressed
Combigan	Brimonidine Tartrate/Timolol	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Perphenazine	Perphenazine	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$328.04 · 3 records	Gilead Sciences, Inc.	Biktarvy, Fetroja, GLYCATE, RELTONE 200 MG, RELTONE 400 MG	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Gilead Sciences, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error